|
HBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.46330000000616E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.04729999999853E-05 |
| Normal-vs-Stage2 |
1.97222999999136E-05 |
| Normal-vs-Stage3 |
3.47460000005295E-06 |
| Normal-vs-Stage4 |
1.01340000002725E-06 |
| Stage1-vs-Stage2 |
1.699040E-01 |
| Stage1-vs-Stage3 |
2.384000E-01 |
| Stage1-vs-Stage4 |
7.454200E-02 |
| Stage2-vs-Stage3 |
6.332000E-01 |
| Stage2-vs-Stage4 |
9.845600E-01 |
| Stage3-vs-Stage4 |
5.745200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.97380000002789E-06 |
| Normal-vs-AfricanAmerican |
2.800000E-02 |
| Normal-vs-Asian |
5.364100E-04 |
| Caucasian-vs-AfricanAmerican |
1.981150E-01 |
| Caucasian-vs-Asian |
4.552600E-01 |
| AfricanAmerican-vs-Asian |
5.297000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75394999999412E-05 |
| Normal-vs-Female |
4.16849999995694E-06 |
| Male-vs-Female |
9.373800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.0285999999925E-05 |
| Normal-vs-Age(41-60Yrs) |
1.86320999999712E-05 |
| Normal-vs-Age(61-80Yrs) |
9.5841000025132E-08 |
| Normal-vs-Age(81-100Yrs) |
1.322200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.670200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.060400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.301200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.327700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.458600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.652000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.815560E-01 |
| Classical-VS-Follicular |
7.636700E-03 |
| Classical-VS-Other |
5.531000E-01 |
| Classical-VS-Normal |
1.431170E-04 |
| Tall-VS-Follicular |
5.182600E-01 |
| Tall-VS-Other |
9.281200E-01 |
| Tall-VS-Normal |
2.40219999999569E-05 |
| Follicular-VS-Other |
7.242600E-01 |
| Follicular-VS-Normal |
1.31960000038234E-07 |
| Other-VS-Normal |
5.291700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30499999995148E-06 |
| Normal-vs-N1 |
1.64076999999985E-05 |
| N0-vs-N1 |
5.920400E-01 |
|
|
